2330
M. Adamczyk, J. Grote / Bioorg. Med. Chem. Lett. 13 (2003) 2327–2330
Table 4. Quantum yields of new probesa
10. Representative example: Rhodamine 6G hydrochloride
(100 mg, 209 mmol) was dissolved in anhydrous DMF (500
mL), and hexanediamine (135 mg, 300 mol%) was added.
After stirring for 12 h, the reaction mixture was purified
directly by preparative reversed phase HPLC (CH3CN/0.05%
aqueous TFA mixtures). Concentration on a rotovap, fol-
lowed by lyophilization, provided 122 mg (79%) of 1a: exci-
tation lmax 530 nm; e530=67,700 (pH 4). Neutralization
(saturated NaHCO3/CH2Cl2) and concentration provided an
off-white solid: 1H NMR (DMSO-d6) d 7.74 (m, 1H), 7.48 (m,
2H), 6.97 (m, 1H), 6.24 (s, 2H), 6.03 (s, 2H), 5.05 (t, 2H,
J=5.2 Hz), 3.26 (s, 4H), 3.11 (m, 3H), 2.92 (m, 2H), 2.41 (t,
2H, J=6.8 Hz), 1.84 (s, 6H), 1.19 (t, 6H, J=6.7 Hz), 0.95 (m,
6H); 13C NMR (DMSO-d6) d 166.7, 153.3, 151.0, 147.6, 147.6,
132.5, 130.8, 128.2, 127.6, 123.6, 122.1, 118.1, 118.1, 104.9,
95.5, 64.2, 41.0, 37.5, 31.9, 27.6, 26.3, 25.8, 17.0, 14.1; ESMS
513.3 (M+H)+.
11. To a solution of 1a (50 mg, 68 mmol) and 6-carboxy-
fluorescein N-hydroxysuccinimide active ester (34 mg, 71
mmol) in anhyd DMF was added diisopropylethylamine (41
mL, 350 mol%). After stirring for 14 hr, the reaction mix-
ture was purified directly by preparative reversed phase
HPLC (CH3CN/0.05% aqueous TFA mixtures). Concen-
tration on a rotovap, followed by lyophilization, provided
28 mg (42%) of 2a: excitation lmax 540 nm, e540=36,200
(pH 4); excitation lmax 497 nm, e497=66,000 (pH 8). Neu-
tralization (pH 6 phosphate buffer) and concentration pro-
vided an off-white solid: 1H NMR (d6DMSO) d 8.43 (m,
1H), 8.01 (d, 1H, J=8.0 Hz), 7.91(d, 1H, J=7.9 Hz), 7.77
(m, 1H), 7.47 (m, 2H), 6.98 (m, 1H), 6.53 (s, 1H), 6.49 (s,
1H), 6.22 (s, 2H), 6.05 (m, 6H), 5.02 (m, 2H), 3.08 (m,
4H), 2.91 br, 2H), 1.82 (s, 6H), 1.17 (m, 6H), 0.95 (m, 6H);
13C NMR (DMSO-d6) d 169.0, 166.7, 165.1, 153.3, 151.0,
147.6, 132.5, 130.9, 130.1, 128.2, 127.6, 123.6, 122.2, 118.2,
109.1, 104.9, 102.5, 95.6, 64.2, 37.5, 28.9, 26.1, 17.0, 14.1;
ESMS 871.5 (M+H)+.
Probe
pH 4b
pH 8c
2a
2b
2c
2d
2e
2f
0.410.24
0.45
0.35
0.82
0.52
0.27
0.19
0.64
0.35
0.23
0.39
aValues are the average of duplicate determinations.
bRelative to rhodamine 6G.
cRelative to 6-carboxyfluoresceine.
Probes 2e and 2f also contain an amine or acid func-
tionality, respectively, making them suitable for cova-
lent attachment to generate a variety of bioprobes.13
Since different rhodamine esters and fluoresceins would
be serve as suitable substrates for this reaction, con-
siderable flexibility in the designer’s fine-tuning of the
fluorescence properties of these broad range fluoro-
phores can be achieved.
References and Notes
1. Abugo, O. O.; Nair, R.; Lakowicz, J. R. Anal. Biochem.
2000, 279, 142.
2. el Jastimi, R.; LaFleur, M. Biospectroscopy 1999, 5, 133.
3. Lan, Z.-H.; Qian, X.; Giese, R. J. Chrom. A 1999, 831, 325.
4. Scaduto, R. C., Jr.; Grotyohann, L. W. Biophys. J. 1999,
76, 469.
5. Mandala, M.; Serck-Hanssen, G.; Martino, G.; Helle, K. B.
Anal. Biochem. 1998, 18, 69.
6. Robey, R. B.; Ruiz, O.; Santos, A.; Ma, J.; Kear, F.; Wang,
L.-J.; Li, C.-J.; Bernardo, A. A.; Arruda, J. A. L. Biochemistry
1998, 37, 9894.
12. Fluorescence emission spectra were obtained on an ISS
PC1spectrofluorometer (Champaign, IL).
7. Lee, R. J.; Wang, S.; Turk, M. J.; Low, P. S. Biosci. Rep.
1998, 18, 69.
8. Handbook of Fluorescent Probes and Research Chemicals,
6th ed.; Haugland, R.P., Ed.; Molecular Probes: Eugene, OR,
1996; p 51.
13. In a trial study, probe 2e was conjugated to an eledoisin
related hexapeptide using TBTU as a coupling reagent. Pur-
ification by reversed-phase HPLC provided a conjugate that
demonstrated 1:1 incorporation (ESMS), and displayed fluo-
rescence properties similar to those of the probe described
above (pH 4: lmax-abs 539, lmax-emis 561; pH 8: lmax-abs 499;
lmax-emis 517).
9. Adamczyk, M.; Grote, J. Bioorg. Med. Chem. Lett. 2000,
10, 1539.